The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans is a research paper published in Cell Metabolism (2023). On theSindex it has a DataRank of 0. It has been cited 89 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Diabetes Research Center
Grant: P30 DK045735
Academy of Finland
Grant: 309263
Pathogenesis of Non-alcoholic Fatty Liver Diseases (NAFLDs) in humans
Academy of Finland
Grant: 350545
Hepatic Mitochondrial Metabolism in Fatty Liver Diseases in Humans
Novo Nordisk Fonden
Grant: NNF18OC0054504
Novo Nordisk Fonden
Grant: NNF19OC0057503
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK113984
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01 DK119968
National Institutes of Health
Grant: 5R01DK113984-04
Effects of Hepatic Acetyl-CoA Carboxylase Inhibition on NAFLD and Hepatic Insulin Resistance
Novo Nordisk Foundation
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01DK119968-02
Development of Controlled Release Mitochondrial Protonophore (CRMP) as a Novel Treatment for Type-2 Diabetes and Non-Alcoholic Steatohepatitis in Dysmetabolic Non-Human Primates
National Institutes of Health
Grant: 5P30DK045735-28
Yale Diabetes Research Center
National Institutes of Health
Sigrid Juséliuksen Säätiö
U.S. Department of Health and Human Services
FWCI
16.31
Citation Percentile
1.0%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals